Following two comprehensive rounds of scoring by more than 100 independent industry judges, the results are in for the MM&M Awards 2014. Here are the five finalists for each of the 31 categories
The deal includes a $1.6-billion fee if AbbVie tries to walk away.
Parent Project Muscular Dystrophy (PPMD) and allied stakeholders recently gave FDA the first patient advocacy-initiated guidance for a rare disease to help accelerate development and review of potential therapies for Duchenne muscular dystrophy.
What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?
Since when was the US better at soccer than advertising?
The new information age in which we live has made it unnecessary for patients to "live in the dark"
Merck and Roche Diagnostics announce job cuts; Novartis abandons an Afinitor study; an FDA advisory committee gives Bayer's lung drug the nod; Vivus still has no plans for Qsymia DTC; and Isis drops development of a mid-stage RA drug